Pharmanutra SpA
MIL:PHN
Wall Street
Price Targets
PHN Price Targets Summary
Pharmanutra SpA
According to Wall Street analysts, the average 1-year price target for
PHN
is 82.28 EUR
with a low forecast of 77.77 EUR and a high forecast of 90.3 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PHN's stock price target?
Price Target
82.28
EUR
According to Wall Street analysts, the average 1-year price target for
PHN
is 82.28 EUR
with a low forecast of 77.77 EUR and a high forecast of 90.3 EUR.
What is Pharmanutra SpA's Revenue forecast?
Projected CAGR
11%
For the last 7 years the
compound annual growth rate for
Pharmanutra SpA's revenue is
17%.
The projected
CAGR
for the next 3 years is
11%.
What is Pharmanutra SpA's Operating Income forecast?
Projected CAGR
13%
For the last 7 years the
compound annual growth rate for
Pharmanutra SpA's operating income is
21%.
The projected
CAGR
for the next 3 years is
13%.
What is Pharmanutra SpA's Net Income forecast?
Projected CAGR
22%
For the last 7 years the
compound annual growth rate for
Pharmanutra SpA's net income is
19%.
The projected
CAGR
for the next 3 years is
22%.
You don't have any saved screeners yet
